Julia Schüler
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
- Oncology 47
- Cancer Cells and Metastasis 23
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Marc P. Stemmler (2 shared papers)Tobias Keck (2 shared papers)Ulrich F. Wellner (2 shared papers)Thomas Brabletz (2 shared papers)Ulrike Burk (2 shared papers)Ulrich T. Hopt (2 shared papers)Simone Brabletz (2 shared papers)Annika Sonntag (1 shared paper)
- Journals
- Cancer Research (15 papers)Blood (7 papers)European Journal of Cancer (5 papers)PLoS ONE (4 papers)Oncotarget (4 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Julia Schüler
106 papers receiving 3.5k citations
Julia Schüler's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 1.0k
- Oncology 1.5k
- Molecular Biology 1.8k
- Immunology 415
- Biotechnology 135
Countries citing papers authored by Julia Schüler
This map shows the geographic impact of Julia Schüler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Schüler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Schüler more than expected).
Fields of papers citing papers by Julia Schüler
This network shows the impact of papers produced by Julia Schüler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Schüler. The network helps show where Julia Schüler may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Schüler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Hit paper breakdown → | 2009 | 1387 |
| 2 | 2018 | 234 | |
| 3 | 2015 | 191 | |
| 4 | 2011 | 114 | |
| 5 | 2017 | 106 | |
| 6 | 2015 | 93 | |
| 7 | 2014 | 85 | |
| 8 | 2011 | 82 | |
| 9 | 2012 | 78 | |
| 10 | 2012 | 72 | |
| 11 | 2021 | 65 | |
| 12 | 2017 | 62 | |
| 13 | 2015 | 59 | |
| 14 | 2013 | 56 | |
| 15 | 2001 | 50 | |
| 16 | Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models. | 2001 | 45 |
| 17 | 2015 | 43 | |
| 18 | Anticancer activity of a lectin-rich mistletoe extract injected intratumorally into human pancreatic cancer xenografts. | 2005 | 42 |
| 19 | 2016 | 36 | |
| 20 | 2022 | 34 |
About Julia Schüler
Julia Schüler is a scholar working on Oncology, Molecular Biology, Immunology, Biomedical Engineering and Biotechnology, having authored 115 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (23 papers), 3D Printing in Biomedical Research (13 papers), Cancer Research and Treatments (12 papers), CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Multiple Myeloma Research and Treatments (7 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.5k citations), Molecular Biology (1.8k citations), Immunology (415 citations) and Biotechnology (135 citations). Julia Schüler has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Marc P. Stemmler, Tobias Keck, Ulrich F. Wellner, Thomas Brabletz, Ulrike Burk, Ulrich T. Hopt, Simone Brabletz, Annika Sonntag, Otto Schmalhofer and Douglas S. Darling. Their work appears in journals such as Cancer Research, Blood, European Journal of Cancer, PLoS ONE and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.